GT Biopharma, Inc. (GTBP) › Total AssetsGT Biopharma, Inc. (GTBP) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $185.0K2011: $129.0K2012: $226.0K2013: $147.0K2014: $888.0K2015: $54.0K2016: $25.0K2017: $254.37M2018: $25.40M2019: $396.0K2020: $5.66M2021: $32.17M2022: $16.74M2023: $14.11M2024: $4.23M2025: $8.11M$8.11M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$8.11M+91.5%2024$4.23M-70.0%2023$14.11M-15.7%2022$16.74M-48.0%2021$32.17M+468.3%2020$5.66M+1329.5%2019$396.0K-98.4%2018$25.40M-90.0%2017$254.37M+1017372.0%2016$25.0K-53.7%2015$54.0K-93.9%2014$888.0K+504.1%2013$147.0K-35.0%2012$226.0K+75.2%2011$129.0K-30.3%2010$185.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share